Loading clinical trials...
Loading clinical trials...
Our study aims to assess the relationship between the Seismofit® derived VO2 peak estimate and CPET-measured VO2 peak in patients who are having CPET as part of their preoperative workup. Our aim is to establish whether Seismofit® can be considered a cheaper, less resource intensive and better tolerated alternative to the CPET, or whether it might be useful as a screening tool to efficiently identify patients with exercise intolerance who may benefit from further characterisation by CPET.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
The Royal Marsden NHS Foundation Trust
London, United Kingdom
Start Date
March 1, 2023
Primary Completion Date
October 1, 2023
Completion Date
March 1, 2024
Last Updated
April 26, 2023
35
ESTIMATED participants
Non-Interventional
OTHER
Lead Sponsor
Royal Marsden NHS Foundation Trust
NCT04704661
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions